Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Medulloblastoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1

Interventions

Radiosurgery 10 Temozolomide 7 pembrolizumab 6 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Nivolumab 4 Bevacizumab 4 Memantine 3 trastuzumab deruxtecan 2 abemaciclib 2 Watchful Waiting 2 Surveys and Questionnaires 2 Receptors, Interleukin-8B 2 Radiotherapy 2 Radiation 2 Mental Status and Dementia Tests 2 Ipilimumab 2 Biopsy 2 vorasidenib 1 sotorasib 1 sapanisertib 1 ribociclib 1 pertuzumab 1 osimertinib 1 lenvatinib 1 fluciclovine F-18 1 entrectinib 1 encorafenib 1 elacestrant 1 dexamethasone acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Diphtheria-Tetanus Vaccine × 30 days × Clear all

NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting

Brain Neoplasms, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡